You are using an outdated browser. Please upgrade your browser to improve your experience.

Tchem
SMARCA2
Probable global transcription activator SNF2L2

Protein Summary
Description
Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Binds DNA non-specifically (PubMed:22952240, PubMed:26601204). Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contai ...more
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000349721
  • ENSP00000265773
  • ENSG00000080503
  • ENST00000357248
  • ENSP00000349788
  • ENST00000382194
  • ENSP00000371629
  • ENST00000382203
  • ENSP00000371638

Symbol
  • BAF190B
  • BRM
  • SNF2A
  • SNF2L2
  • BRM
  • SNF2
  • SWI2
  • hBRM
  • NCBRS
  • Sth1p
  • BAF190
  • SNF2L2
  • SNF2LA
  • hSNF2a
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
molecular function
1
protein domain
1
PubMedID
0.99
hub protein
0.96
disease perturbation
0.95


IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 448.21   (req: < 5)
Gene RIFs: 112   (req: <= 3)
Antibodies: 200   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 448.21   (req: >= 5)
Gene RIFs: 112   (req: > 3)
Antibodies: 200   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 18
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligands: 15
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0